clinical evaluation of siddha drug kukkilathi chooranam in excessive white discharge(leucorrhoea)patients of age group 18 to 60

phase II non randomized open clinical evaluation of siddha drug kukkilathi chooranam in kabayonirogam(vulvovaginal candidiasis)in female of age between 18 to 60 patients attending opd at AAGHIM attached with GSMC

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/08/020842

Enrollment

Registered

2019-08-22

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B373- Candidiasis of vulva and vagina

Interventions

Intervention1: Kukkilathi chooranam: 4 gms twice a day with ghee for 48 days Control Intervention1: nil: nil

Eligibility

Inclusion criteria

Inclusion criteria: patients with the symptoms of whitish (curdy like) discharge vulvovaginal itching erosions inflammation surface is covered by whitish coat known case of DM positive candida albicans

Exclusion criteria

Exclusion criteria: Known case of sexually transmitted disease (Gonorrhea,Syphilis,HIV) Known case of Nonspecific leucorrhea (Douches,Pessaries,tampons,trauma,drugs,chemicals) Pregnancy and lactation Known case of malignancy in uterus and ovary Vulvovagainosis caused by other organism

Design outcomes

Primary

Measure	Time frame
outcome is assessed by wet mount examination and clinical prognosisTimepoint: After 48 days	—

Secondary

Measure	Time frame
outcome is assessed by comparing the safety parameters before and after treatmentTimepoint: 48 days	—

Countries

India

Contacts

Public ContactDr S Bharathi

Government siddha medical college chennai

chittu758@gmail.com9444177230

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026